MMP14‐Dependent Activation of TGF‐β Signaling Enhances Malignancies via Promoting Necroptosis in Glioblastoma
The FASEB Journal · 2025
DOI: 10.1096/fj.202501932r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Haoyu Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Glioblastoma, Necroptosis, Transforming Growth Factor beta, Matrix Metalloproteinase 14. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Innovation Capacity Support Plan of Shaanxi Province, | Natural Science Basic Research Program of Shaanxi Province ().
Abstract (Originalsprache)
Glioblastoma (GBM) exhibits profound genetic heterogeneity and poor prognosis, and a wide range of biological processes are proved to be enrolled in its tumorigenesis and progression. Necroptosis, which is identified as a regulated cell death process, has been widely confirmed to be essential in shaping malignant behaviors among multiple tumors; nevertheless, the functions of necroptosis in GBM still remain elusive. Herein, matrix metalloproteinase‐14 (MMP14) was identified as a necroptosis‐related hub gene in GBM by using weighted gene co‐expression network analysis (WGCNA) of bulk transcriptomic data. Moreover, single‐cell analysis and spatial transcriptomics mapped a cell subpopulation in which MMP14 and necroptosis are closely correlated. Additionally, MMP14 emerged as a poor prognostic marker in GBM. Functionally, knockdown of MMP14 suppressed GBM malignant behavior, including proliferation, immigration, invasion, and tumorigenesis, with an increased susceptibility to necroptosis. As an underlying mechanism, TGF‐β signaling was critical for MMP14‐mediated necroptosis activation, with SMAD Family Member 2 (SMAD2) directly binding to the Receptor‐Interacting Protein 1 (RIP1) promoter. Altogether, MMP14 promotes a range of malignant behaviors and orchestrates a TGF‐β‐dependent necroptosis heterogeneity landscape in GBM; therefore, targeting MMP14‐TGF‐β signaling could be a novel strategy to counteract therapeutic resistance in GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Center for Brain Science, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
ORCID-Profile: Haoyu Zhou
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Innovation Capacity Support Plan of Shaanxi Province
- | Natural Science Basic Research Program of Shaanxi Province ()
- The First Affiliated Hospital of Xi'an jiaotong University Scientific Research Foundation
- National Natural Science Foundation of China
- Natural Science Basic Research Program of Shaanxi Province
Zitieren
APA
Zhou, H., Wu, W., Cao, Y., Zhang, B., Zhou, M., Wang, Y., Wang, M., & Wang, J. (2025). MMP14‐Dependent Activation of TGF‐β Signaling Enhances Malignancies via Promoting Necroptosis in Glioblastoma. The FASEB Journal. https://doi.org/10.1096/fj.202501932r
Vancouver
Zhou H, Wu W, Cao Y, Zhang B, Zhou M, Wang Y, et al. MMP14‐Dependent Activation of TGF‐β Signaling Enhances Malignancies via Promoting Necroptosis in Glioblastoma. The FASEB Journal. 2025. doi:10.1096/fj.202501932r
BibTeX
@article{Zhou2025,
author = {Zhou, Haoyu and Wu, Wei and Cao, Yiyang and Zhang, Beichen and Zhou, Mingjing and Wang, Yichang and Wang, Maode and Wang, Jia},
title = {MMP14‐Dependent Activation of TGF‐β Signaling Enhances Malignancies via Promoting Necroptosis in Glioblastoma},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202501932r}
}
EUVIMED